Logo image of RUG.CA

RUGBY RESOURCES LTD (RUG.CA) Stock Fundamental Analysis

TSX-V:RUG - TSX Venture Exchange - CA78132X1042 - Common Stock - Currency: CAD

0.04  0 (0%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to RUG. RUG was compared to 806 industry peers in the Metals & Mining industry. RUG may be in some trouble as it scores bad on both profitability and health. RUG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RUG had negative earnings in the past year.
In the past year RUG has reported a negative cash flow from operations.
In the past 5 years RUG always reported negative net income.
RUG had a negative operating cash flow in each of the past 5 years.
RUG.CA Yearly Net Income VS EBIT VS OCF VS FCFRUG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -405.62%, RUG is doing worse than 86.10% of the companies in the same industry.
Industry RankSector Rank
ROA -405.62%
ROE N/A
ROIC N/A
ROA(3y)-1202.98%
ROA(5y)-776.18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RUG.CA Yearly ROA, ROE, ROICRUG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20K 40K 60K 80K 100K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for RUG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RUG.CA Yearly Profit, Operating, Gross MarginsRUG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for RUG has been increased compared to 1 year ago.
Compared to 5 years ago, RUG has more shares outstanding
The debt/assets ratio for RUG is higher compared to a year ago.
RUG.CA Yearly Shares OutstandingRUG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
RUG.CA Yearly Total Debt VS Total AssetsRUG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

Based on the Altman-Z score of -95.63, we must say that RUG is in the distress zone and has some risk of bankruptcy.
RUG's Altman-Z score of -95.63 is on the low side compared to the rest of the industry. RUG is outperformed by 84.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -95.63
ROIC/WACCN/A
WACCN/A
RUG.CA Yearly LT Debt VS Equity VS FCFRUG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

2.3 Liquidity

A Current Ratio of 0.45 indicates that RUG may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.45, RUG is doing worse than 69.23% of the companies in the same industry.
RUG has a Quick Ratio of 0.45. This is a bad value and indicates that RUG is not financially healthy enough and could expect problems in meeting its short term obligations.
RUG has a worse Quick ratio (0.45) than 67.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.45
RUG.CA Yearly Current Assets VS Current LiabilitesRUG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 73.72% over the past year.
EPS 1Y (TTM)73.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%224.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
RUG.CA Price Earnings VS Forward Price EarningsRUG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RUG.CA Per share dataRUG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RUG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RUGBY RESOURCES LTD

TSX-V:RUG (7/28/2025, 7:00:00 PM)

0.04

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-25 2025-07-25
Earnings (Next)10-23 2025-10-23
Inst Owners1.01%
Inst Owner ChangeN/A
Ins Owners5.91%
Ins Owner ChangeN/A
Market Cap16.68M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -405.62%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1202.98%
ROA(5y)-776.18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.45
Quick Ratio 0.45
Altman-Z -95.63
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%224.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y69.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.85%
OCF growth 3YN/A
OCF growth 5YN/A